Airway-Therapeutics
Cincinnati, US · 1 known investors
Airway Therapeutics is a biotech company developing inhaled therapeutics for inflammatory and infectious lung diseases, including programs targeting bronchopulmonary dysplasia, acute respiratory distress syndrome, and pulmonary fibrosis.
BiotechDigital HealthHealthtechMedical Devices
Investors · 1
Competitors · 3
by search overlapAertherapeutics7 shared keywordsAer Therapeutics develops a science-driven therapeutic aimed at eliminating mucus plugs in the lungs to treat muco-obstructive lung diseases such as COPD and asthma. The company focuses on respiratory care for patients with these conditions.
Apogee Therapeutics6 shared keywordsApogee Therapeutics develops novel antibody therapeutics targeting biological drivers of inflammatory and immune diseases, aiming to improve on the standard of care. Its pipeline addresses dermatological, respiratory, and gastroenterological conditions.
Seamless5 shared keywordsSeamless.AI is a real-time search engine and sales intelligence platform that finds and verifies B2B prospect contact data, automates outreach, and books meetings. It serves revenue teams including sales leaders, SDRs, account executives, RevOps, and marketing.
Companies competing with Airway-Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Airway-Therapeutics do?
- Airway Therapeutics is a biotech company developing inhaled therapeutics for inflammatory and infectious lung diseases, including programs targeting bronchopulmonary dysplasia, acute respiratory distress syndrome, and pulmonary fibrosis.
- Who are Airway-Therapeutics's investors?
- Airway-Therapeutics's investors include CincyTech.
- Where is Airway-Therapeutics headquartered?
- Airway-Therapeutics is headquartered in Cincinnati, US.